NCCN

Recent news mentioning NCCN

• 2026-07-30 — Newly FDA-Approved REVTORPYK™ (gedatolisib) Included in the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines for HR+/HER2- Locally Advanced or Metastatic Breast Cancer
• 2026-07-29 — IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®

Appears alongside

• IceCure
• SIO
• FDA
• ProSense

Browse the full archive →